EQS Newswire / 13/02/2023 / 09:59 UTC+8 Suzhou, February 10, 2023 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced the positive top-line results from the U.S. Phase I clinical trial of GT20029, a Kintor Pharma in-house developed and fully owned proteolysis targeting chimera (PROTAC) compound. […]
Tag: trial
Fuel Cell Bus Trials on the BRT Hikoboshi Line
TOKYO, Feb 8, 2023 – (JCN Newswire via SEAPRWire.com) – Fukuoka Prefecture, Commercial Japan Partnership Technologies Corporation (CJPT), and Kyushu Railway Company (JR Kyushu) have entered an agreement to conduct trials of a small fuel cell electric bus (FC bus) that runs on hydrogen, an environmentally-friendly next-generation energy source, on the BRT Hikoboshi Line (officially […]
DOCOMO Conducts World’s First Trial of Transmissive Metasurface on Window to Deliver Indoor Radio Waves to Outdoor Foot of Building
TOKYO, Jan 30, 2023 – (JCN Newswire via SEAPRWire.com) – NTT DOCOMO, INC. announced today that it has succeeded in what it believes to be the world’s first trial of redirecting millimeter-band (28 GHz) radio waves coming from inside a building to the foot of the building outdoors by bending the radio waves with a […]
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826’s Treatment of Female Androgenetic Alopecia in China Was Met
EQS Newswire / 02/12/2022 / 10:34 UTC+8 Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826’s Treatment of Female Androgenetic Alopecia in China Was Met Suzhou, December 1, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced […]
Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use
EQS Newswire / 24/11/2022 / 09:48 UTC+8 Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use Suzhou, November 24, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced the top-line results for its phase […]
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US
EQS Newswire / 27/10/2022 / 17:58 UTC+8 Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in the US Suzhou, October 27, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced that the company […]
SC orders anti-Red official to comment on lawyers’ contempt plea
THE SUPREME Court (SC) has ordered a former anti-communist spokesperson of the government to comment on an indirect contempt petition filed against her by several lawyers for allegedly threatening a trial court judge online. In a statement dated Oct. 18 and sent to reporters on Wednesday, the tribunal gave ex-spokesperson Lorrain Marie T. Badoy 15 […]
Court rejects NTC plea on blocking Bulatlat website
A QUEZON City trial court has rejected a government appeal to set aside a ruling that unblocked Bulatlat.com’s news website. In a resolution dated Oct. 10 and sent to reporters on Wednesday, the court said blocking the website violated its freedom of speech and of the press. “As a result of the blocking, plaintiff is […]
Appeals court denies Ressa’s plea to reverse cyber-libel conviction
THE PHILIPPINE Court of Appeals (CA) has denied the petition of Rappler, Inc. founder Maria A. Ressa to reconsider her conviction for cyber-libel. In a 16-page resolution on Oct. 10 and made public on Tuesday, the CA Fourth Division said the appeal failed to raise any new arguments to overturn the decision. “A careful and […]
Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day
EQS Newswire / 08/09/2022 / 23:42 EST/EDT Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit Interim data from Phase 1/2 glycogen storage disease 1a (GSD1a) single-dose […]
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
SYDNEY, Sep 2, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution of Clinical Trials in the Asia Pacific Region”. The report was prepared by GlobalData and confirms that “the Asia-Pacific (APAC) region was the largest contributor […]
Kintor 2022 Interim Results: Pruxelutamide and KX-826 show positive results, business value has been presented
EQS Newswire / 30/08/2022 / 11:13 UTC+8 Kintor 2022 Interim Results: Pruxelutamide and KX-826 show positive results, business value has been presented Suzhou, August 29, 2022 – Kintor Pharmaceutical Limited (“Kintor Pharma” or “the Company”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced its 2022 interim results […]
Zhaoke Ophthalmology Announces 2022 Interim Results
HONG KONG, Aug 24, 2022 – (ACN Newswire via SEAPRWire.com) – Zhaoke Ophthalmology Limited (“Zhaoke Ophthalmology” or the “Company”, SEHK: 6622), a leading ophthalmic pharmaceutical company dedicated to the research and development, manufacturing and commercialization of therapies that address significant unmet medical needs, today announced its interim results for the six months ended 30 June […]
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully
HONG KONG, Aug 15, 2022 – (ACN Newswire via SEAPRWire.com) – On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. R&G Pharmastudies publicly issued 15,000,000 shares at a price of RMB78.88 per share, and the […]
Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans
NEW YORK, NY, Aug 9, 2022 – (ACN Newswire via SEAPRWire.com) – PCG Digital — Life may change for the better for the 10 million Americans suffering from fibromyalgia. The development-stage biotech Virios Therapeutics, Inc. (Nasdaq:VIRI) is anticipating the reporting of phase 2b treatment results for its lead fibromyalgia treatment candidate this September and continues […]
Oculis Announces First Patient Enrolled in Phase 3 OPTIMIZE Trial of OCS-01 in the Treatment of Inflammation and Pain Following Cataract Surgery
LAUSANNE, Switzerland, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A., (Oculis) a global ophthalmology company developing life-changing treatments to save sight and improve eye care with breakthrough innovations, today announced that the first patient has been enrolled in its Phase 3 OPTIMIZE (Once-daily Post ocular surgery Treatment for InflaMmation and paIn to […]
Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022
SEOUL, S.KOREA, Jun 29, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today awarded the Best Biologics CRO Award at a ceremony as part of 11th Biologics Manufacturing Korea, the 6th Cell & Gene Therapy World East Asia, […]
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
HONG KONG, Jun 15, 2022 – (ACN Newswire via SEAPRWire.com) – SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, today announced that, the first healthy subject […]
Novotech’s APAC and USA Leadership Teams at BIO 2022
SAN DIEGO, CA, Jun 14, 2022 – (ACN Newswire via SEAPRWire.com) – Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key executives from APAC and the US attend BIO 2022 for meetings with biotechs considering the Asia-Pacific region to expedite their clinical trials. #4907 […]
Eisai Initiates Preparation for New Drug Application, Based on the Results of an Investigator-Initiated Clinical Trial of Ultrahigh-Dose Mecobalamin for Amyotrophic Lateral Sclerosis in Japan
TOKYO, May 10, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. today announced that it has initiated preparation on a New Drug Application for ultrahigh-dose mecobalamin (development code: E0302) for amyotrophic lateral sclerosis (ALS) in Japan, based on a favorable clinical results of the JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for […]